STOCK TITAN
  1. Home
  2. SEC Filings
  3. SNOW
  4. [Form 4] Snowflake Inc. Insider Trading Activity

Snowflake director exercises options, sells 300,000 shares

Filing Impact
(Neutral)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
4

Rhea-AI Filing Summary

Snowflake Inc. director Frank Slootman exercised fully vested stock options to acquire 300,000 shares of common stock at an exercise price of $8.880 per share on July 20–21, 2026, then sold 300,000 shares in multiple transactions at weighted-average prices between $267.380 and $278.700 per share under a Rule 10b5-1 trading plan adopted on September 19, 2025.

Insider Slootman Frank
Role Director
Sold 300,000 shs ($82.32M)
Approx. gross sale proceeds $82.32M
Approx. exercise cost $2.66M
Approx. pre-tax spread $79.66M
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F1, F25 10,315 $0.00 $0.00
Exercise Common Stock F1, F2 10,315 $8.88 $92K
Sale Common Stock F1, F13, F2 632 $269.582 $170K
Sale Common Stock F1, F14, F2 281 $270.622 $76K
Sale Common Stock F1, F15, F2 1,297 $271.507 $352K
Sale Common Stock F1, F16, F2 1,078 $272.834 $294K
Sale Common Stock F1, F17, F2 600 $274.082 $164K
Sale Common Stock F1, F18, F2 1,945 $275.234 $535K
Sale Common Stock F1, F19, F2 2,699 $277.537 $749K
Sale Common Stock F1, F20, F2 1,783 $278.24 $496K
Exercise Stock Option (Right to Buy) F1, F25 289,685 $0.00 $0.00
Exercise Common Stock F1, F2 289,685 $8.88 $2.57M
Sale Common Stock F1, F3, F2 958 $267.765 $257K
Sale Common Stock F1, F4, F2 808 $269.483 $218K
Sale Common Stock F1, F5, F2 9,723 $270.536 $2.63M
Sale Common Stock F1, F6, F2 11,352 $271.418 $3.08M
Sale Common Stock F1, F7, F2 25,182 $272.314 $6.86M
Sale Common Stock F1, F8, F2 36,567 $273.468 $10.00M
Sale Common Stock F1, F9, F2 95,030 $274.51 $26.09M
Sale Common Stock F1, F10, F2 59,978 $275.391 $16.52M
Sale Common Stock F1, F11, F2 48,058 $276.265 $13.28M
Sale Common Stock F1, F12, F2 2,029 $277.029 $562K
holding Common Stock F21 -- -- --
holding Common Stock F22 -- -- --
holding Common Stock F23 -- -- --
holding Common Stock F24 -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 4,736,655 contracts (Direct); Common Stock — 28,535 shares (Direct); Common Stock — 207,855 shares (Indirect, Trust)
Footnotes (25)
  1. F1. The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.
  2. F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
  3. F3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $267.380 to $267.980, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
  4. F4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $268.805 to $269.780, inclusive.
  5. F5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $269.830 to $270.825, inclusive.
  6. F6. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $270.900 to $271.890, inclusive.
  7. F7. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $271.900 to $272.890, inclusive.
  8. F8. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $272.920 to $273.915, inclusive.
  9. F9. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $273.920 to $274.915, inclusive.
  10. F10. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $274.920 to $275.915, inclusive.
  11. F11. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $275.930 to $276.870, inclusive.
  12. F12. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $276.940 to $277.250, inclusive.
  13. F13. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $269.200 to $270.110, inclusive.
  14. F14. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $270.230 to $271.060, inclusive.
  15. F15. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $271.280 to $272.030, inclusive.
  16. F16. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $272.380 to $273.300, inclusive.
  17. F17. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $273.420 to $274.410, inclusive.
  18. F18. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $274.730 to $275.720, inclusive.
  19. F19. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $277.000 to $277.990, inclusive.
  20. F20. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $278.000 to $278.700, inclusive.
  21. F21. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
  22. F22. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee.
  23. F23. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
  24. F24. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
  25. F25. The stock option is fully vested.
Shares from options exercised 300,000 shares Total underlying common shares from stock options exercised on July 20–21, 2026
Option exercise price $8.8800 per share Exercise price of stock options converted into common stock
Shares sold 300,000 shares Total Snowflake common shares sold in multiple transactions on July 20–21, 2026
Lowest disclosed sale price $267.380 per share Low end of disclosed sale price range in weighted-average price footnotes
Highest disclosed sale price $278.700 per share High end of disclosed sale price range in weighted-average price footnotes
10b5-1 plan adoption date September 19, 2025 Adoption date of Rule 10b5-1 trading plan governing these transactions
Option expiration date May 28, 2029 Expiration date of the fully vested stock options prior to exercise
Rule 10b5-1 trading plan regulatory
"were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted-average price financial
"The price reported in Column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
restricted stock units financial
"shares to be issued in connection with the vesting of one or more restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Grantor Retained Annuity Trust financial
"2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Snowflake (SNOW) director Frank Slootman report?
Frank Slootman exercised fully vested stock options to acquire 300,000 Snowflake shares at $8.880 per share, then sold 300,000 common shares in multiple trades at weighted-average prices between $267.380 and $278.700 per share on July 20–21, 2026. All transactions were reported in this Form 4 filing.

Were Frank Slootman’s Snowflake (SNOW) share trades made under a Rule 10b5-1 plan?
Yes. All reported exercises and sales were effected under a Rule 10b5-1 trading plan that Frank Slootman adopted on September 19, 2025. This plan-based structure is disclosed in the Form 4 footnotes linked to each transaction.

What stock options did Snowflake (SNOW) director Frank Slootman exercise?
He exercised fully vested stock options covering 300,000 shares of Snowflake common stock at an exercise price of $8.880 per share. These options, described as fully vested in a footnote, had an expiration date of May 28, 2029 before exercise.

At what prices did Frank Slootman sell Snowflake (SNOW) shares?
He sold 300,000 Snowflake common shares at reported weighted-average prices, with disclosed transaction ranges spanning from $267.380 to $278.700 per share. Individual sale blocks, such as 95,030 and 59,978 shares, each have specific weighted-average prices noted.

On which dates did the Snowflake (SNOW) insider transactions occur?
The reported option exercises and related common stock sales occurred on July 20, 2026 and July 21, 2026. Both days include option exercises at $8.880 per share and multiple sale transactions at weighted-average prices detailed in the Form 4 footnotes.

Does Frank Slootman report any indirect Snowflake (SNOW) holdings in trusts?
Yes. He reports indirect ownership in several trusts, including the Slootman Grandchildren's Trust, the Slootman 2023 Children's Trust, and two Grantor Retained Annuity Trusts. Footnotes clarify his or his spouse’s role as trustee for these trust-held Snowflake shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Accepted by SEC EDGAR
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Slootman Frank
(Last)(First)(Middle)
C/O SNOWFLAKE INC.
135 CONSTITUTION DRIVE
(Street)
MENLO PARK CALIFORNIA 94025
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Snowflake Inc. [ SNOW ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/20/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/20/2026M(1)289,685A$8.88318,220(2)D
Common Stock07/20/2026S(1)958D$267.765(3)317,262(2)D
Common Stock07/20/2026S(1)808D$269.483(4)316,454(2)D
Common Stock07/20/2026S(1)9,723D$270.536(5)306,731(2)D
Common Stock07/20/2026S(1)11,352D$271.418(6)295,379(2)D
Common Stock07/20/2026S(1)25,182D$272.314(7)270,197(2)D
Common Stock07/20/2026S(1)36,567D$273.468(8)233,630(2)D
Common Stock07/20/2026S(1)95,030D$274.51(9)138,600(2)D
Common Stock07/20/2026S(1)59,978D$275.391(10)78,622(2)D
Common Stock07/20/2026S(1)48,058D$276.265(11)30,564(2)D
Common Stock07/20/2026S(1)2,029D$277.029(12)28,535(2)D
Common Stock07/21/2026M(1)10,315A$8.8838,850(2)D
Common Stock07/21/2026S(1)632D$269.582(13)38,218(2)D
Common Stock07/21/2026S(1)281D$270.622(14)37,937(2)D
Common Stock07/21/2026S(1)1,297D$271.507(15)36,640(2)D
Common Stock07/21/2026S(1)1,078D$272.834(16)35,562(2)D
Common Stock07/21/2026S(1)600D$274.082(17)34,962(2)D
Common Stock07/21/2026S(1)1,945D$275.234(18)33,017(2)D
Common Stock07/21/2026S(1)2,699D$277.537(19)30,318(2)D
Common Stock07/21/2026S(1)1,783D$278.24(20)28,535(2)D
Common Stock16,300ITrust(21)
Common Stock78,893ITrust(22)
Common Stock56,331ITrust(23)
Common Stock56,331ITrust(24)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$8.8807/20/2026M(1)289,685 (25)05/28/2029Common Stock289,685$04,746,970D
Stock Option (Right to Buy)$8.8807/21/2026M(1)10,315 (25)05/28/2029Common Stock10,315$04,736,655D
Explanation of Responses:
1. The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025.
2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.
3. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $267.380 to $267.980, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
4. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $268.805 to $269.780, inclusive.
5. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $269.830 to $270.825, inclusive.
6. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $270.900 to $271.890, inclusive.
7. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $271.900 to $272.890, inclusive.
8. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $272.920 to $273.915, inclusive.
9. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $273.920 to $274.915, inclusive.
10. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $274.920 to $275.915, inclusive.
11. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $275.930 to $276.870, inclusive.
12. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $276.940 to $277.250, inclusive.
13. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $269.200 to $270.110, inclusive.
14. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $270.230 to $271.060, inclusive.
15. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $271.280 to $272.030, inclusive.
16. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $272.380 to $273.300, inclusive.
17. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $273.420 to $274.410, inclusive.
18. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $274.730 to $275.720, inclusive.
19. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $277.000 to $277.990, inclusive.
20. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $278.000 to $278.700, inclusive.
21. The shares are held by the Slootman Grandchildren's Trust dated 7/28/2022 for which the Reporting Person is a trustee.
22. The shares are held by the Slootman 2023 Children's Trust dated 9/25/2023 for which the Reporting Person is a trustee.
23. The shares are held by the F. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person is the trustee.
24. The shares are held by the B. Slootman 2024 Grantor Retained Annuity Trust dated 12/3/2024 for which the Reporting Person's spouse is the trustee.
25. The stock option is fully vested.
Remarks:
/s/ Marie Reider, Attorney-in-Fact07/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Keep reading

More on SNOW

All SNOW news

Trending in the feed

NOK
Nokia Corporation Interim Report for Q3 2026 Open the live feed